/PRNewswire/ Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis,.
Curaleaf Holdings, Inc (CURLF) Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe s Leading Independent Cannabis Company EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom, Germany, Italy, Spain, and Portugal With the European Population of Nearly 748 Million
1, the Potential Addressable Market is More than Twice the Size of U.S. Market 10 March, London. EMMAC Life Sciences Group, Europe s largest independent cannabis company, is pleased to announce that it is has signed a definitive agreement to be acquired by Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ( Curaleaf or the Company ), a leading U.S. provider of consumer products in cannabis, for a base consideration of approximately US$285 million to be paid in 85%/15% Curaleaf shares and cash. Contingent
Share this article
WAKEFIELD, Mass., March 9, 2021 /PRNewswire/
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ( Curaleaf or the Company ), a leading U.S. provider of consumer products in cannabis, today announced that it has signed a definitive agreement to acquire EMMAC Life Sciences Limited ( EMMAC ), the largest vertically integrated independent cannabis company in Europe for base consideration of approximately US$286 million to be paid 85% in Curaleaf subordinate voting shares and 15% in cash. Contingent consideration of up to US$57 million will be paid in Curaleaf subordinate voting shares and cash in the same ratio based upon the successful achievement of performance milestones. The proposed transaction provides Curaleaf with a developed platform for entry into the European cannabis market.
Curaleaf Executives to Present at the Benzinga Cannabis Capital Conference
News provided by
Share this article
WAKEFIELD, Mass., Feb. 24, 2021 /PRNewswire/
Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF) ( Curaleaf or the Company ), a leading U.S. provider of consumer products in cannabis, today announced that Boris Jordan, Curaleaf Executive Chairman, and Sarah-Marie Cole, Curaleaf Regional Vice President of Marketing, will be presenting at the Benzinga Cannabis Capital Conference on February 25, 2021.
Boris Jordan, Executive Chairman, will be the opening keynote speaker for the Conference on February 25, 2021 at 9:10 am EST. The discussion will be moderated by Jason Raznick, Benzinga Chief Executive Officer.